Advertisement

Socio-cultural and Economic Concerns on Use of Convalescent Blood or Plasma for the Management of Ebola Virus Disease in Africa

  • Nchangwi Syntia Munung
  • Godfrey B. Tangwa
  • David Houeto
  • Awa Keita
  • J. Radeino Ambe
  • Akin Abayomi
Chapter

Abstract

The 2014 Ebola outbreak in West Africa, which started on December 2013, but commonly known as the 2014 Ebola outbreak led to an urgent need for effective and affordable treatment options for Ebola Virus Disease (EVD). While there are a number of experimental drugs for the treatment of EVD, there is also a parallel interest in the use of human convalescent blood or plasma for the treatment of EVD as well as a post-exposure prophylaxis. The use of human convalescent plasma as a form of therapy in an epidemic situation has its challenges and raises a number of socio-cultural issues that need to be taken into consideration when planning interventions. In this chapter, we discuss these socio-cultural concerns and challenges. We also suggest that the successful use of convalescent plasma for therapy or as a post exposure prophylaxis, would require: active community engagement; effective public education; collaborations that are equitable; and building trust between the general public and other stakeholders (researchers, funders, civil societies, healthcare workers and humanitarian organizations) involved in trials on human convalescent therapy.

Notes

Acknowledgement

We thank Alice Mungwa for inputs in the initial draft of the manuscript.

References

  1. Agasa, S. B., & Likwela, J. L. (2014). Barriers to voluntary blood donation in the population of Kisangani in the Democratic Republic of Congo. The Pan African Medical Journal, 17, 306.  https://doi.org/10.11604/pamj.2014.17.306.2663.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Ala, F., Allain, J. P., Bates, I., Boukef, K., Boulton, F., Brandful, J., Dax, E. M., El Ekiaby, M., Farrugia, A., Gorlin, J., Hassall, O., Lee, H., Loua, A., Maitland, K., Mbanya, D., Mukhtar, Z., Murphy, W., Opare-Sem, O., Owusu-Ofori, S., Reesink, H., Roberts, D., Torres, O., Totoe, G., Ullum, H., & Wendel, S. (2012). External financial aid to blood transfusion services in sub-Saharan Africa: A need for reflection. PLoS Medicine, 9(9), e1001309.  https://doi.org/10.1371/journal.pmed.1001309.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Allain, J. P., Sarkodie, F., Boateng, P., Asenso, K., Kyeremateng, E., & Owusu-Ofori, S. (2008). A pool of repeat blood donors can be generated with little expense to the blood center in sub-Saharan Africa. Transfusion, 48(4), 735–741.  https://doi.org/10.1111/j.1537-2995.2007.01599.x.CrossRefPubMedGoogle Scholar
  4. Burnouf, T., & Seghatchian, J. (2014). “Go no go” in plasma fractionation in the world’s emerging economies: Still a question asked 70 years after the COHN process was developed! Transfusion and Apheresis Science, 51(2), 113–119.  https://doi.org/10.1016/j.transci.2014.10.002.CrossRefPubMedGoogle Scholar
  5. Butler, D. (2014). First trials of blood-based Ebola therapy kick off. Nature News. Accessed 18 May 2015. http://www.nature.com/news/first-trials-of-blood-based-ebola-therapy-kick-off-1.16564
  6. Dewar, H. A. (1946). Treatment of typhoid fever with convalescent whole blood. Journal of the Royal Army Medical Corps, 86, 249–253.PubMedGoogle Scholar
  7. Dye, J. M., Herbert, A. S., Kuehne, A. I., Barth, J. F., Muhammad, M. A., Zak, S. E., Ortiz, R. A., Prugar, L. I., & Pratt, W. D. (2012). Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proceedings of the National Academy of Sciences of the United States of America, 109(13), 5034–5039.  https://doi.org/10.1073/pnas.1200409109.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Folayan, M. O., Brown, B., Haire, B., Yakubu, A., Peterson, K., & Tegli, J. (2015). Stakeholders’ engagement with Ebola therapy research in resource limited settings. BMC Infectious Diseases, 15(1), 242.  https://doi.org/10.1186/s12879-015-0950-8.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Frame, J. D., Verbrugge, G. P., Gill, R. G., & Pinneo, L. (1984). The use of Lassa fever convalescent plasma in Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 78(3), 319–324.CrossRefGoogle Scholar
  10. Houéto, D., & Deccache, A. (2007). Child malaria in sub-saharan Africa: Effective control and prevention require a health promotion approach. International Quarterly of Community Health Education, 28(1), 51–62.  https://doi.org/10.2190/IQ.28.1.e.CrossRefPubMedGoogle Scholar
  11. Jacobs, B., & Berege, Z. A. (1995). Attitudes and beliefs about blood donation among adults in Mwanza region, Tanzania. East African Medical Journal, 72(6), 345–348.PubMedGoogle Scholar
  12. Jensen, C. (1935). The 1934 epidemic of poliomyelitis in Denmark. Preliminary report on the epidemiology, clinical features and convalescent serum therapy: (Section of pathology). Proceedings of the Royal Society of Medicine, 28(8), 1007–1026.CrossRefGoogle Scholar
  13. Kebede, S., Duales, S., Yokouide, A., & Alemu, W. (2010). Trends of major disease outbreaks in the African region, 2003–2007. East African Journal of Public Health, 7(1), 20–29.PubMedGoogle Scholar
  14. Kinsman, J. (2012). “A time of fear”: Local, national, and international responses to a large Ebola outbreak in Uganda. Globalization and Health, 8, 15.  https://doi.org/10.1186/1744-8603-8-15.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Kombe, F., Folayan, M. O., Ambe, J., Igonoh, A., & Abayomi, A. (2016). Taking the bull by the horns: Ethical considerations in the design and implementation of an Ebola virus therapy trial. Social Science & Medicine, 148, 163–170.Google Scholar
  16. Koster, J., & Hassall, O. W. (2011). Attitudes towards blood donation and transfusion in Bamenda, Republic of Cameroon. Transfusion Medicine, 21(5), 301–307.  https://doi.org/10.1111/j.1365-3148.2011.01079.x.CrossRefPubMedGoogle Scholar
  17. Lachmann, P. J. (2012). The use of antibodies in the prophylaxis and treatment of infections. Emerging Microbes & Infections, 1, e11.CrossRefGoogle Scholar
  18. Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J. K., Cleary, P., Khaw, F. M., Lim, W. S., Makki, S., Rooney, K. D., & Beck, C. R. (2015). The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis. The Journal of Infectious Diseases, 211(1), 80–90.  https://doi.org/10.1093/infdis/jiu396.CrossRefPubMedGoogle Scholar
  19. Marmot, M. (2000). Multilevel approaches to understanding social determinants. In L. F. K. Berkman (Ed.), Social epidemiology (pp. 349–367). New York: Oxford University Press.Google Scholar
  20. Marmot, M., Friel, S., Bell, R., Houweling, T. A. J., Taylor, S., & on behalf of the Commission on Social Determinants of Health. (2008). Closing the gap in a generation: Health equity through action on the social determinants of health. The Lancet, 372(9650), 1661–1669.  https://doi.org/10.1016/S0140-6736(08)61690-6.CrossRefGoogle Scholar
  21. Mupapa, K., Massamba, M., Kibadi, K., Kuvula, K., Bwaka, A., Kipasa, M., Colebunders, R., & Muyembe-Tamfum, J. J. (1999). Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. Journal of Infectious Diseases, 179(Suppl 1), S18–S23.  https://doi.org/10.1086/514298.CrossRefPubMedGoogle Scholar
  22. Nebie, K. Y., Olinger, C. M., Kafando, E., Dahourou, H., Diallo, S., Kientega, Y., Domo, Y., Kienou, K., Ouattara, S., Sawadogo, I., Ky, L., & Muller, C. P. (2007). Lack of knowledge among blood donors in Burkina Faso (West Africa); potential obstacle to transfusion security. Transfusion Clinique et Biologique, 14(5), 446–452.  https://doi.org/10.1016/j.tracli.2007.12.005.CrossRefPubMedGoogle Scholar
  23. Ngu, V. A., & Ambe, F. A. (2001). Effective vaccines against and immunotherapy of the HIV: A preliminary report. Journal of the Cameroon Academy of Science, 1(1), 2–8.Google Scholar
  24. Ngu, V. A., Ambe, F. A., & Boma, G. A. (2002). Significant reduction of HIV loads in the sera of patients treated with VANHIVAX. Journal of the Cameroon Academy of Science, 2(1), 7–12.Google Scholar
  25. Ngu, V. A., Besong-Egbe, B. H., Ambe, F. A., Ngu, J. A., & Caspa, C. G. (2007). The conversion of HIV sero-positive to sero-negative following VANHIVAX. Journal of the Cameroon Academy of Science, 7(1), 17–20.Google Scholar
  26. Olaiya, M. A., Alakija, W., Ajala, A., & Olatunji, R. O. (2004). Knowledge, attitudes, beliefs and motivations towards blood donations among blood donors in Lagos, Nigeria. Transfusion Medicine, 14(1), 13–17.  https://doi.org/10.1111/j.0958-7578.2004.00474.x.CrossRefPubMedGoogle Scholar
  27. Osaro, E., & Charles, A. T. (2011). The challenges of meeting the blood transfusion requirements in sub-Saharan Africa: The need for the development of alternatives to allogenic blood. Journal of Blood Medicine, 2, 7–21.  https://doi.org/10.2147/JBM.S17194.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Owusu-Ofori, S., Asenso-Mensah, K., Boateng, P., Sarkodie, F., & Allain, J. P. (2010). Fostering repeat donations in Ghana. Biologicals, 38(1), 47–52.  https://doi.org/10.1016/j.biologicals.2009.10.021.CrossRefPubMedGoogle Scholar
  29. Pollack, A. (2014, October 3). A plan to use survivors’ Blood for Ebola treatment in Africa. The New York Times. Accessed 19 May 2015. http://www.nytimes.com/2014/10/04/health/use-of-ebola-survivors-blood-as-possible-treatment-gains-support.html.
  30. Ravi, S. J., & Gauldin, E. M. (2014). Sociocultural dimensions of the Ebola virus disease outbreak in Liberia. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 12(6), 301–305.  https://doi.org/10.1089/bsp.2014.1002.CrossRefGoogle Scholar
  31. Reidpath, D. D. (2004). Social determinants of health. In H. Keleher & B. Murphy (Eds.), Understanding health: A determinants approach (pp. 9–22). Oxford: Oxford University Press.Google Scholar
  32. Shears, P. (2000). Emerging and reemerging infections in africa: The need for improved laboratory services and disease surveillance. Microbes and Infection, 2(5), 489–495.CrossRefGoogle Scholar
  33. Souké, G. (2014). Propagation du virus Ebola au Mali: l’irresponsabilité de la Clinique Pasteur. Mali24, Last Modified 13 November 2014, Accessed 11 June. http://www.mali24.info/dossier/sante/831-propagation-du-virus-ebola-au-mali-l-irresponsabilite-de-la-clinique-pasteur.
  34. Tangwa, G. B. (2004). Bioethics, biotechnology and culture: A voice from the margins. Developing World Bioethics, 4(2), 125–138.  https://doi.org/10.1111/j.1471-8731.2004.00088.x.CrossRefPubMedGoogle Scholar
  35. Tangwa, G. B. (2010). Elements of African bioethics in a Western Frame. Mankon/Bamenda: Langaa Research & Publishing CIG.Google Scholar
  36. Tapko, J., Mainuka, P., & Diarra-Nama, A. J. (2007). Status of blood safety in the WHO African region: Report of the 2006 survey. Accessed 12 May 2015. http://www.afro.who.int/en/divisions-a-programmes/dsd/health-technologies-a-laboratories.html.
  37. Tapko, J. B., Toure, B., & Sambo, L. G. (2014). Status of blood safety in the WHO African region: Report of the 2010 survey. Brazzaville/Republic of Congo: WHO Regional Office for Africa.Google Scholar
  38. Tutu, D. (1999). No future without forgiveness. New York: Doubleday.CrossRefGoogle Scholar
  39. Umeora, O. U., Onuh, S. O., & Umeora, M. C. (2005). Socio-cultural barriers to voluntary blood donation for obstetric use in a rural Nigerian village. African Journal of Reproductive Health, 9(3), 72–76.CrossRefGoogle Scholar
  40. WHO. (2015a). The Ebola outbreak in Liberia is over.Google Scholar
  41. WHO. (2015b). Ebola transmission in Liberia over. Nation enters 90-day intensive surveillance period.Google Scholar
  42. WHO. (2015c). Ebola virus disease. Fact sheet N°103.Google Scholar
  43. Zingher, A. (1924). Convalescent whole blood, plasma and serum in prophylaxis of measles. Journal of the American Medical Association, 82(15), 1180–1187.  https://doi.org/10.1001/jama.1924.02650410022011.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Nchangwi Syntia Munung
    • 1
    • 2
  • Godfrey B. Tangwa
    • 3
    • 4
    • 2
  • David Houeto
    • 5
  • Awa Keita
    • 6
  • J. Radeino Ambe
    • 7
    • 8
  • Akin Abayomi
    • 2
    • 9
    • 10
  1. 1.Department of MedicineUniversity of Cape TownCape TownSouth Africa
  2. 2.Global Emerging Pathogen Treatment Consortium (GET) ConsortiumLagosNigeria
  3. 3.Department of PhilosophyUniversity of Yaounde 1YaoundeCameroon
  4. 4.Cameroon Bioethics Initiative (CAMBIN)YaoundeCameroon
  5. 5.School of Public HealthUniversity of ParakouParakouRepublic of Benin
  6. 6.Centre for Research on SCDBamakoMali
  7. 7.Department of Public Health, School of Nursing and Health SciencesCapella UniversityMinneapolisUSA
  8. 8.The Global Emerging Pathogens Treatment InitiativeLagosNigeria
  9. 9.Nigerian Medical Research Institute (NIMR)LagosNigeria
  10. 10.Faculty of Medicine and Health SciencesUniversity of StellenboschStellenboschSouth Africa

Personalised recommendations